Ignite Creation Date:
2024-05-05 @ 11:45 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00124748
Status:
TERMINATED
Last Update Posted:
2012-02-03
First Post:
2005-07-27
Brief Title:
Efficacy of 400 Mg Versus 800 Mg Imatinib in Chronic Myeloid Leukemia in Chronic Phase Patients - TOPS Tyrosine Kinase Inhibitor Optimization and Selectivity
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-06
Start Date Type:
None
Primary Completion Date:
2010-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-11
Completion Date Type:
ACTUAL
First Submit Date:
2005-07-27
First Submit QC Date:
July 27 2005
Study First Post Date:
2005-07-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2012-02-03
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-01-05
Last Update Post Date:
2012-02-03
Last Update Post Date Type:
ESTIMATED